The CEO's $3.82M sale is the largest single insider transaction in the cluster and follows a material agreement (IMPAVIDO deal) by only 9 days. While insider sells are generally weaker signals than buys, the timing and magnitude warrant monitoring for any negative developments or guidance changes at the next earnings release.
Price Chart
Executive Summary
Eton Pharmaceuticals CEO Sean Brynjelsen sold $3.82M worth of stock and CBO David Krempa sold $1.80M (including derivative exercises) in the week following the company's May 19 agreement to acquire U.S. commercialization rights to IMPAVIDO for up to $8.25M. The $4.44M total insider selling represents 0.51% of the $873M market cap, crossing the 0.5% materiality threshold.
Key Financial Metrics
Key Facts
- CEO Sean Brynjelsen sold 119,852 shares at $31.88 for $3.82M on 2026-05-28
- CBO David Krempa sold 57,203 shares total at ~$31.48 for $1.80M on 2026-05-26/27
- Krempa exercised 62,476 derivative shares at $0-$1.38 (non-cash and cash exercises) alongside sales
- Total insider selling of $4.44M equals 0.51% of $873M market cap
- Sales occurred 9-10 days after Eton's May 19 IMPAVIDO licensing deal (8-K filed 2026-05-19)
- No insider purchases in the cluster — 100% selling direction
- Recent 30-day insider activity shows $6.7M in total sells prior to this cluster
Financial Impact
CEO and CBO sold $4.44M combined, representing 0.51% of market cap
Risk Factors
- CEO selling $3.82M post-material-agreement could signal insider concern about deal economics or near-term outlook
- No insider buying to offset the selling — one-sided bearish signal
- CBO exercised low-cost derivatives and immediately sold, typical of compensation liquidation but adds to selling pressure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ETON-1780085946904 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | 8-K | $52.88 | awaiting T+60 | — | $51.16 (−3.25%) |
Oct 6, 2026 21d ago | 144 | $54.88 | awaiting T+60 | — | $51.16 (−6.78%) |
Sep 28, 2026 29d ago | 8-K | $59.18 | awaiting T+60 | — | $51.16 (−13.55%) |
Aug 31, 2026 8w ago | Insider Cluster | $60.43 | awaiting T+60 | — | $51.16 (−15.34%) |
Aug 28, 2026 8w ago | Insider Cluster | $60.44 | awaiting T+60 | — | $51.16 (−15.35%) |
Aug 24, 2026 9w ago | Insider Cluster | $63.05 | awaiting T+60 | — | $51.16 (+18.86%) |
Aug 19, 2026 9w ago | 144 | $61.48 | awaiting T+60 | — | $51.16 (+16.79%) |
Aug 5, 2026 11w ago | 8-K | $45.97 | awaiting T+60 | — | $51.16 (+11.29%) |
Aug 5, 2026 11w ago | Press Release | $45.97 | awaiting T+60 | — | $51.16 (+11.29%) |
Aug 4, 2026 12w ago | 8-K | $45.83 | awaiting T+60 | — | $51.16 (+11.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers